Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Thomas

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
The Oncologist|April 3, 2023
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid TumorsMeredith LaRose, Roisin M Connolly, Ciara C O'Sullivan, et al.
Cancer|July 4, 2014
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125Raffit Hassan, Elad Sharon, Anish Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 21, 2022
An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLCKristen Fousek, Lucas A Horn, Haiyan Qin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Characterization of fibroblast growth factor receptor 1 in small-cell lung cancerAnish Thomas, Jih-Hsiang Lee, Zied Abdullaev, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Circulating Tumor Cells Are Detectable and Independent of PSA and PSMA-PET Metrics in Localized High-Risk and Biochemically Recurrent Prostate CancerShraddha Rastogi, Nahoko Sato, Sunmin Lee, et al.
The Journal of Applied Laboratory Medicine|October 30, 2018
Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung CancerYunkai Yu, Bríd M Ryan, Anish Thomas, et al.
JNCI Cancer Spectrum|June 21, 2019
Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung CancerJennifer S Davis, Erin Prophet, Ho-Lan Peng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2016
Malignant Mesothelioma Effusions Are Infiltrated by CD3<sup>+</sup> T Cells Highly Expressing PD-L1 and the PD-L1<sup>+</sup> Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody AvelumabSwati Khanna, Anish Thomas, Daniel Abate-Daga, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Characterization and management of cardiac involvement of thymic epithelial tumorsAnish Thomas, Sujata Shanbhag, Karl Haglund, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
The Oncologist|April 3, 2023
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid TumorsMeredith LaRose, Roisin M Connolly, Ciara C O'Sullivan, et al.
Cancer|July 4, 2014
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125Raffit Hassan, Elad Sharon, Anish Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 21, 2022
An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLCKristen Fousek, Lucas A Horn, Haiyan Qin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Characterization of fibroblast growth factor receptor 1 in small-cell lung cancerAnish Thomas, Jih-Hsiang Lee, Zied Abdullaev, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Circulating Tumor Cells Are Detectable and Independent of PSA and PSMA-PET Metrics in Localized High-Risk and Biochemically Recurrent Prostate CancerShraddha Rastogi, Nahoko Sato, Sunmin Lee, et al.
The Journal of Applied Laboratory Medicine|October 30, 2018
Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung CancerYunkai Yu, Bríd M Ryan, Anish Thomas, et al.
JNCI Cancer Spectrum|June 21, 2019
Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung CancerJennifer S Davis, Erin Prophet, Ho-Lan Peng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2016
Malignant Mesothelioma Effusions Are Infiltrated by CD3<sup>+</sup> T Cells Highly Expressing PD-L1 and the PD-L1<sup>+</sup> Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody AvelumabSwati Khanna, Anish Thomas, Daniel Abate-Daga, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Characterization and management of cardiac involvement of thymic epithelial tumorsAnish Thomas, Sujata Shanbhag, Karl Haglund, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Pageof 17